SAFIED 50MG TAB Bygliv Met Tablet making it ideal for patients

making it ideal for patients with deficiency or those requiring enhanced B12 supplementation

puncture sites

Ideal for adults and children over 12 years of age

Ideal for patients with eczema or dermatitis who have not responded adequately to conventional treatments

Report any adverse effects to your healthcare professional

SAFIED 50MG TAB Bygliv Met Tablet making it ideal for patientsSAFIDE 50MG contains Safinamide Mesylate, a monoamine oxidase (MAO) inhibitor used as an adjunctive treatment for Parkinson's disease. This medication helps reduce motor fluctuations and improve symptom control in patients already taking levodopa therapy. Safinamide works by inhibiting MAO B enzyme activity, prolonging dopamine availability in the brain. Suitable for adults with mid to late stage Parkinson's disease experiencing motor complications.